Cardiovascular Drugs and Therapy

, Volume 25, Issue 4, pp 349–362

Mesenchymal Stem Cells for Cardiovascular Regeneration

Review Article

DOI: 10.1007/s10557-011-6311-y

Cite this article as:
Kuraitis, D., Ruel, M. & Suuronen, E.J. Cardiovasc Drugs Ther (2011) 25: 349. doi:10.1007/s10557-011-6311-y


Despite recent studies suggesting that the heart has instrinsic mechanisms of self-regeneration following myocardial infarction, it cannot regenerate itself to an optimal level. Mesenchymal stem cells (MSCs) are currently being investigated for regeneration of mesenchyme-derived tissues, such as bone, cartilage and tendon. In vitro evidence suggests that MSCs can also differentiate into cardiomyogenic and vasculogenic lineages, offering another cell source for cardiovascular regeneration. In vivo, MSCs may contribute to the re-growth and protection of vasculature and cardiomyocytes, mediated by paracrine actions, and/or persist within the myocardium in a differentiated state; although proof of cardiomyocytic phenotype and functional integration remains elusive. Herein, we review the evidence of MSCs as a cell source for cardiovascular regeneration, as well as their limitations that may prevent them from being effectively used in the clinic.

Key words

Cardiovascular Regeneration Cell Therapy Mesenchymal Stem Cell Neovascularization 

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Drew Kuraitis
    • 1
    • 2
  • Marc Ruel
    • 1
    • 2
  • Erik J. Suuronen
    • 1
    • 2
  1. 1.Division of Cardiac SurgeryUniversity of Ottawa Heart InstituteOttawaCanada
  2. 2.Department of Cellular & Molecular MedicineUniversity of OttawaOttawaCanada

Personalised recommendations